Please note: AABB reserves the right to make updates to this program.
Tuesday, March 13, 2018
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 18EL-322 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Managers/Supervisors, Medical Director, Nurses, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologist, Transfusion Safety Officer
Teaching Level: Basic to Intermediate
Director: Barbee Whitaker, PhD, Senior Director, Research, AABB, Bethesda, MD
Moderator: Mark Fung, M.D., Ph.D., University of Vermont Medical Center, Burlington, VT
Presenters: Chester Andrzejewski, MD, Medical Director, System Transfusion Medicine, Baystate Medical Center, Springfield, MA; Sarah Vossoughi, Columbia University Medical Center, New York, NY; Kathryn Haass, BB(ASCP), MPH, Health Research Analyst, CDC, Atlanta, GA; Barbee Whitaker, PhD, Senior Director, Research, AABB, Bethesda, MD
After participating in this educational activity, participants should be able to:
- Demonstrate the use of the CDC NHSN Hemovigilance Module.
- Define hemovigilance and explain its use and impact in the practice of transfusion medicine.
- Recognize how hemovigilance benchmarking can be used to improve patient safety.
- Contrast transfusion reactions in the pediatric populations with those of the adult population.
This program is designed to provide an introduction to hemovigilance. The history of hemovigilance, what's new in the US CDC National Healthcare Safety Network (NHSN) Hemovigilance Modules, and the ongoing benefits of participation will be discussed. A live demonstration of the CDC National Healthcare Safety Network Hemovigilance Module will allow users to visualize the hemovigilance experience. Instructions for how to get started using hemovigilance definitions, how to enter data into the CDC NHSN Hemovigilance Module, and how to join the AABB Center for Patient Safety will be explained. The use of pediatric hemovigilance data will be discussed in the context of patient safety.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Kathryn Haass is a Health Scientist at the Centers for Disease Control and Prevention. Her primary activities include conducting the National Blood Collection and Utilization Survey (NBCUS) and operating the National Healthcare Safety Network (NHSN) Hemovigilance Module. Prior to joining CDC, Kathryn worked as a Medical Technologist in blood bank and microbiology.
Dr. Whitaker is Senior Director of the Department of Research for AABB. She is also the Senior Director of the AABB Center for Patient Safety, which has been designated an official patient safety organization by the Agency for Healthcare Research and Quality of the Department of Health and Human Services. She is responsible for AABB’s hemovigilance activities in coordination with hospitals, blood centers and the federal government.